Medicinal mushrooms native to Slovenia
DOI:
https://doi.org/10.14720/abs.56.2.15554Keywords:
medicinal mushrooms, Slovenia, polysaccharides, cancer, natural remedies, endangered fungiAbstract
Slovenia with its diverse environment is home to more than 2400 fungal species out of which especially many macromycetes have for millennia been used worldwide as natural remedies. These species of mushrooms were in the past picked from the nature, but today can be cultivated as fruiting bodies or fungal biomass on different substrates. They possess immunomodulating, antiviral, antibacterial and anticancer activities and can be used against allergies, dementia, Alzheimer disease and in many other diseases. They represent a vast potential as natural remedies with no or very little adverse effects and can be processed into food supplement or further developed into medicines. These mushrooms are a natural treasure, which enables us to be more self-sufficient if we cultivate them for medical and certain species for nutritional purposes as well.
References
Abdulla, M.A., Noor, S.M., Sabaratnam, V., Abdullah, N., Wong, K.H., Ali, H.M., 2009. Effect of Culinary-Medicinal Lion’s Mane Mushroom, Hericium erinaceus (Bull.: Fr.) Pers. (Aphyllophoromycetideae), on Ethanol-Induced Gastric Ulcers in Rats. Int. J. Med. Mushr., 11 (3), 325–336. DOI: https://doi.org/10.1615/IntJMedMushr.v10.i4.40
Bauerova, K., Paulovicova, E., Mihalova, D., Svik, K., Ponist, S., 2009. Study of new ways of supplementary and combinatory therapy of rheumatoid arthritis with immunomodulators. Glucomannan and Imunoglukan in adjuvant arthritis. Toxicol. Ind. Health, 25 (4–5), 329–335. DOI: https://doi.org/10.1177/0748233709102945
Bobek, P., Giner, E., Kuniak, L., Babala, J., Jurcovicova, M., Ozdin, L., Cerven, J., 1991. Effect of mushroom Pleurotus ostreatus and isolated fungal polysaccharide on serum and liver lipids in Syrian hamsters with hyperlipoproteinemia. Nutrition, 7 (2), 105–108.
Bobek, P., Ozdin, L., Kajaba, I., 1997. Dose-dependent hypocholesterolaemic effect of oyster mushroom (Pleurotus ostreatus) in rats. Physiol. Res., 46 (4), 327–329.
Boh, B., 2013. Ganoderma lucidum: A Potential for Biotechnological Production of Anti-Cancer and Immunomodulatory Drugs. Recent Patents on Anti-Cancer Drug Discovery, 8, 255–287. DOI: https://doi.org/10.2174/1574891X113089990036
Boh, B., Berovič, M., Zhang, J.S., Zhi-Bin, L., 2007. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnology Annual Review, 13, 265–301. DOI: https://doi.org/10.1016/S1387-2656(07)13010-6
Capasso, L., 1998. 5300 years ago, the Ice man used natural laxatives and antibiotics. Lancet, 352, 1864. DOI: https://doi.org/10.1016/S0140-6736(05)79939-6
Cha, J.Y., Ahn, H.Y., Cho, Y.S., Je, J.Y., 2013. Protective effect of cordycepin-enriched Cordyceps militaris on alcoholic hepatotoxicity in Sprague–Dawley rats. Food and Chemical Toxicology, 60, 52–57. DOI: https://doi.org/10.1016/j.fct.2013.07.033
Chang, S.T., 1996. Mushroom research and development – equality and mutual benefits. Proceedings of the 2nd International conference on Mushroom Biology and Mushroom Products, Pennsilvanya, 581 pp.
Chang, S.T., 1999. World production of cultivated and medicinal mushrooms in 1997 with emphasis on Lentinus edodes (Berk) Sing. Int. J. Med. Mush., 1, 291–300. DOI: https://doi.org/10.1615/IntJMedMushr.v1.i4.10
Chang, S.T., Buswell, J.A., 1999. Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae) – a mushrooming medicinal mushroom. Int. J. Med. Mushrooms, 1 (2), 139–146. DOI: https://doi.org/10.1615/IntJMedMushrooms.v1.i2.30
Chang, S.T., Buswell, J.A., Miles, P.G., (eds.) 1992. Genetics and breeding of edible mushrooms. 2nd ed. Gordon & Breach Science Publishers, New York, 324 pp.
Chang, S.T., Miles, P.G., 1987. Historical record of the early cultivation of Lentinus in China. Mushroom Journal of the Tropics, 7, 47.
Chen, G., Luo, Y.C., Li, B.P., Li, B., Guo, Y., Li, Y., Su, W., Xiao, Z.L., 2008. Effect of polysaccharide from Auricularia auricula on blood lipid metabolism and lipoprotein lipase activity of ICR mice fed a cholesterol-enriched diet. J. food. Sci., 73 (6), 103–108. DOI: https://doi.org/10.1111/j.1750-3841.2008.00821.x
Chen, W., Zhao, Z., Chen, S.F., Li, Y.Q., 2008. Optimization for the production of exopolysaccharide from Fomes fomentarius in submerged culture and its antitumor effect in vitro. Bioresource Technology, 99, 3187–3194. DOI: https://doi.org/10.1016/j.biortech.2007.05.049
Cheng, J.J., Lin, C.Y., Lur, H.S., Chen, H.P., Lu, M.K., 2008. Properties and biological functions of polysaccharides and ethanolic extracts isolated from medicinal fungus, Fomitopsis pinicola. Process Biochemistry, 43, 829–834. DOI: https://doi.org/10.1016/j.procbio.2008.03.005
Cui, J., Chisti, Y., 2003. Polysaccharopeptides of Coriolus versicolor: physiological activity, uses, and production. Biotechnol. Adv., 21 (2), 109–122. DOI: https://doi.org/10.1016/S0734-9750(03)00002-8
Dakskobler, I., Seliškar, A., Podgornik, G., 2011. Razširjenost in ekologija vrste Laricifomes officinalis (Vill.) Kotl. & Pouzar v Julijskih Alpah (Slovenija); Distribution and ecology of Laricifomes officinalis (Vill.) Kotl. & Pouzar in the Julian Alps (Slovenia). Gozd, 69, 139–153.
Evans, S., Kibby, G., 2005. Naturfuehrer, Pilze, 1st ed. Dorling Kindersley, Starnberg, 296 pp.
Fisher, M., Yang, L.X., 2002. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Anticancer Res., 22 (3), 1737–1754.
Gao, Y., Zhou, Sh., Chen, G., Dai, X., Ye, J., 2002. A phase I= II study of a Ganoderma lucidum (Curt.:Fr.) P. Karst. extract (Ganopoly) in patients with advanced cancer. Int. J. Med. Mushrooms, 2002, 4 (3), 207–214. DOI: https://doi.org/10.1615/IntJMedMushr.v4.i3.30
Gregori, A., Piskur, B., Gregori, M., Jurc, D., 2007a: Spread of the Fomitopsis officinalis inoculated in stems of living larch in Slovenia, The fourth international medicinal mushroom conference, Ljubljana, 304–305.
Gregori, A., Švagelj, M., Pohleven, J., 2007b. Cultivation Techniques and Medicinal Properties of
Pleurotus spp. Food Technol. Biotechnol., 45 (3), 236–247.
Gu, Y.H., Sivam, G., 2006. Cytotoxic effect of oyster mushroom Pleurotus ostreatus on human androgen-independent prostate cancer PC-3 cells. J. Med. Food., 9 (2), 196–204. DOI: https://doi.org/10.1089/jmf.2006.9.196
Gunde-Cimerman, N., Plemenitas, A., 2001. Hypocholesterolemic Activity of the Genus Pleurotus (Jacq.: Fr.) P. Kumm. (Agaricales s. I., Basidiomycetes), Int. J. Med. Mushr., 3 (4), 395–398. DOI: https://doi.org/10.1615/IntJMedMushr.v3.i4.90
Haghi, A. K., 2011. Food Science: Research and Technology. CRC Press, 131 pp. DOI: https://doi.org/10.1201/b12234
Hirose, K., Hakozaki, M., Kakuchi, I., Matsunaga, K., Yoshikumi, C., Takakashi, M., Tochikura, T.S., Yamamoto, N., 1987. A biological response modifier, PSK, inhibits reverse transcriptase in vitro. Biochem. Biophys. Res. Commun., 149 (2), 562–567. DOI: https://doi.org/10.1016/0006-291X(87)90404-9
Hobbs, C., 2004. Medicinal Value of Turkey Tail Fungus Trametes versicolor (L.:Fr.) Pilat (Aphyllosphoromycetideae), Int. J. Med. Mushr., 6 (3), 346–347. DOI: https://doi.org/10.1615/IntJMedMushr.v7.i3.100
Hobbs, Ch., 1995. Medicinal Mushrooms: An Exploration of Tradition, Healing, and Culture , 2nd Ed., Botanica Press, Inc.: Santa Cruz, CA, USA.
Holliday, J., Cleaver, M., 2005. Cordyceps, Encyclopedia of Dietary Supplements. New York: Marcel Dekker, pp. 842.
Hossain, S., Hashimoto, M., Choundhury, E.K., Alam, N., Hussain, S., Hasan, M., Choudhury, S.K., Mahmud, I., 2003. Dietary mushroom (Pleurotus ostreatus) ameliorates atherogenic lipid in hypercholesterolaemic rats. Clin. Exp. Pharmacol. Physiol., 30 (7), 470–475. DOI: https://doi.org/10.1046/j.1440-1681.2003.03857.x
Hung, L.T., Keawsompong, S., Hanh, V.T., Sivichai, S., Hywel-Jones, N.L., 2009. Effect of temperature on cordycepin production in Cordyceps militaris. Thai journal of agricultural science, 42 (4), 219–225.
Ito, H., Sugiura, M., Miyazaki, T., 1976. Antitumor polysaccharide fraction from the culture filtrate of Fomes fomentarius. Chemical & pharmaceutical bulletin, 24 (10), 2575. DOI: https://doi.org/10.1248/cpb.24.2575
Jayakumar, T., Ramesh, E., Geraldine, P., 2006. Antioxidant activity of the oyster mushroom, Pleurotus ostreatus, on CCl(4)-induced liver injury in rats. Food Chem. Toxicol., 44 (12), 1989–1996. DOI: https://doi.org/10.1016/j.fct.2006.06.025
Jayakumar, T., Thomas, P.A., Geraldine, P., 2007. Protective effect of an extract of the oyster mushroom, Pleurotus ostreatus, on antioxidants of major organs of aged rats. Epx. Gerontol., 42 (3), 183–191. DOI: https://doi.org/10.1016/j.exger.2006.10.006
Jimenez-Medina, E., Berruguilla, E., Romero, I., Algarra, I., Collado, A., Garrido, F., Garcia-Lora, A., 2008. The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis. BMC Cancer, 8,78. DOI: https://doi.org/10.1186/1471-2407-8-78
Jin, X., Ruiz, B.J., Sze, D.M.Y., Chan, G.C.F., 2012. Ganoderma lucidum (Reishi mushroom) for cancer treatment (Review). Cochrane database syst. Rev., 13 (6), 1–35. DOI: https://doi.org/10.1002/14651858.CD007731.pub2
Jong, S.C., Birmingham, J.M., 1992. Medicinal benefits of the mushroom Ganoderma. Adv. Appl. Microbiol., 37, 101–134. DOI: https://doi.org/10.1016/S0065-2164(08)70253-3
Jurc, D., Piltaver, A., Ogris, N., 2005. Glive Slovenije – Fungi of Slovenia, Studia forestalica Slovenica, Ljubljana, 497 pp.
Kamo, T., Asanoma, M., Shibata, H., Hirota, M., 2003. Anti-inflammatory lanostane-type triterpene acids from Piptoporus betulinus. Journal of Natural Products, 66 (8), 1104–1106. DOI: https://doi.org/10.1021/np0300479
Kanamoto, T., Kashiwada, Y., Kanbara K., Gotoh, K., Yoshimori, M., Goto, T., Sano, K., 2001. Anti-human immunodeficiency virus activity of YI-FH 312 (a betulinic acid derivative), a novel compound blocking viral maturation. Antimicrobial Agents and Chemotherapy, 45 (4), 1225–1230. DOI: https://doi.org/10.1128/AAC.45.4.1225-1230.2001
Kanazawa, M., Yoshihara, K., Abe, H., Iwadate, M., Watanabe, K., Suzuki, S., Endoh, Y., Takita, K., Sekikawa, K., Takenoshita, S., Ogata, T., Ohto, H., 2005. Effects of PSK on T and dendritic cells differentiation in gastric or colorectal cancer patients. Anticancer Res., 25 (1B), 443–449.
Kano, R., Oomae, S., Nakano, Y., Minami, T., Sukikara, M., Nakayama, T., Hasegawa, A., 2002. First Report on Schizophyllum commune from a Dog. J. Clin. Microbiol., 40 (9), 3535–3537. DOI: https://doi.org/10.1128/JCM.40.9.3535-3537.2002
Kawagishi, H., 2005. Anti-MRSA compounds of Hericium erinaceus. Int. J. Med. Mushr., 7 (3), 350. DOI: https://doi.org/10.1615/IntJMedMushrooms.v7.i3.130
Kawagishi, H., Simada, A., Shizuki, K., Ojima, F., Mori, H., Okamoto, K., Sakamoto, H., Furukawa, S., 2011. Erinacine D, a stimulator of NGF-synthesis, from the mycelia of Hericium erinaceum. Heterocyclic Communications, 2 (1). DOI: https://doi.org/10.1515/HC.1996.2.1.51
Kenmoku, H., Shimai, T., Toyomasu, T., Kato, N., Sassa, T., 2002. Erinacine Q, a new erinacine from Hericium erinaceum, and its biosynthetic route to erinacine C in the basidiomycete. Biosci. Biotechnol. Biochem., 66 (3), 571–575. DOI: https://doi.org/10.1271/bbb.66.571
Khan, A., Tania, M., Liu, R., Rahman, M.M., 2013. Hericium erinaceus: an edible mushroom with medicinal values. J. Complement. Integr. Med., 10 (1), 1–6. DOI: https://doi.org/10.1515/jcim-2013-0001
Kim, H.W., Kim, B.K., 1999. Biomedical triterpenoids of Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae). Int. J. Med. Mushrooms, 1 (2), 121–138. DOI: https://doi.org/10.1615/IntJMedMushrooms.v1.i2.20
Kim, J.R., Yeon, S.H., Kim, H.S., Ahn, Y.J., 2002. Larvicidal acivity against Plutella xylostella of cordycepin from the fruiting body of Cordyceps militaris. Pest Manag., 58, 713–717. DOI: https://doi.org/10.1002/ps.508
Kirk, P.M., Cannon, P.F., David, J.C., Stalpers, J.A., 2001. Ainsworth and Bisby’s dictionary of the fungi, 9th ed. CAB International, Walingford.
Koc, Y., Urbano, A.G., Sweeney E.B., McCaffrey, R., 1996. Induction of apoptosis by cordycepin in ADA-inhibited TdT–positive leukemia cells. Leukemia, 10, 1019–1024.
Kodama, N., Komuta, K., Nanba, H., 2002. Can maitake MD-fraction aid cancer patients? Alter. Med. Rev., 7 (3), 236–239.
Kodama, N., Komuta, K., Nanba, H., 2003. Effect of Maitake (Grifola frondosa) D Fraction on the activation of NK cells in cancer patients. J. Med. Food, 6 (4), 371–377. DOI: https://doi.org/10.1089/109662003772519949
Kolotushkina, E.V., Moldavan, M.G., Voronin, K.Y., Skibo, G.G., 2003. The influence of Hericium erinaceus extract on myelination process in vitro. Fiziol. Zh., 49 (1), 38–45.
Komatsu, N., Okubo, S., Kikumoto, S., Kimura, K., Saito, G., 1969. Host-mediated antitumor action of Schizophyllan, a glucan produced by Schizophyllum commune. Gann., 60, 137–144.
Kubo, K., Aoki, H., Nanba, H., 1994. Anti-diabetic activity present in the fruit body of Grifola frondosa (Maitake). Biol. Pharm. Bull., 17, 1106–1110. DOI: https://doi.org/10.1248/bpb.17.1106
Kubo, K., Nanba, H., 1997. Anti-hyperliposis effect of Maitake fruit body (Grifola frondosa). Biol. Pharm. Bull., 20, 781–785. DOI: https://doi.org/10.1248/bpb.20.781
Kurashige, S., Akuzawa, Y., Endo, F., 1997. Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine. Immunopharmacol. Immunotoxicol., 19 (2), 175–183. DOI: https://doi.org/10.3109/08923979709007657
Lee, J.S., Hong, E.K., 2010. Hericium erinaceus enhances doxorubicininduced apoptosis in human hepatocellular carcinoma cells. Cancer Lett., 297, 144–154. DOI: https://doi.org/10.1016/j.canlet.2010.05.006
Lee, S.I., Kim, J.S., Oh, S.H., Park, K.Y., Lee, H.G., Kim, S.D., 2008. Antihyperglycemic Effect of Fomitopsis pinicola Extracts in Streptozotocin-Induced Diabetic Rats, Journal of Medicinal Food. September 2008, 11 (3), 518–524. DOI: https://doi.org/10.1089/jmf.2007.0155
Lee, S.Y., Debnath, T., Kim, S.K., Lim, B.O., 2013. Anti-cancer effect and apoptosis induction of cordycepin through DR3 pathway in the human colonic cancer cell HT-29. Food and chemical toxicology, 60, 439–447. DOI: https://doi.org/10.1016/j.fct.2013.07.068
Lemieszek, M.K., Langner, E., Kaczor, J., Kandefer-Szerszen, M., Sanecka, B., Mazurkiewicz, W., Rzeski, W., 2009. Anticancer Effect of Fraction Isolated from Medicinal Birch Polypore Mushroom, Piptoporus betulinus (Bull.: Fr.) P. Karst. (Aphyllophoromycetideae): In Vitro Studies. Int. DOI: https://doi.org/10.1615/IntJMedMushr.v11.i4.20
J. Med. Mushr., 11 (4) 351–364.
Lindequist, U., Niedermeyer, T.H.J., Juelich, W.D., 2005. The pharmacological potential of mushrooms. Evidence-based Complementary and Alternative Medicine, 2, 285–299. DOI: https://doi.org/10.1093/ecam/neh107
Liu, C., Gao, P., Qian, J., Yan, W., 2000. Immunological study on the antitumor effects of fungus polysaccharides compounds. Wei Sheng Yan Jiu, 29, 178–180.
Manez. S., Recio, M.C., Giner, R.M., Rios, J.L., 1997. Effect of selected triterpenoids on chronic dermal inflammation. European Journal of Pharmacology, 334 (1), 103–105. DOI: https://doi.org/10.1016/S0014-2999(97)01187-4
Mayell, M., 2001. Maitake extracts and their therapeutic potential. Altern. Med. Rev., 6 (1), 48–60.
McKenna, D.J., Jones, K., Hughes, K., 2002. Reishi Botanical Medicines. The Desk reference for Major Herbal Supplements, 2nd Ed., The Haworth Herbal Press: New York, London, Oxford, 825–855.
Miyazaki, K., Mizutani, H., Katabuchi, H., Fukuma, K., Fujisaki, S., Okamura, H. 1995. Activated (HLA–DR+) T-lymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with Schizophyllan on cell-mediated immunity and survival. Gynecologic oncology, 56, 412–420. DOI: https://doi.org/10.1006/gyno.1995.1073
Mizuno, T., 1995. Reishi, Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects. Food Rev. Int., 11 (1), 151–166. DOI: https://doi.org/10.1080/87559129509541025
Mlinarič, A., Kac, J., Pohleven, F., 2005. Screening of selected wood-damaging fungi for the HIV-1 reverse transcriptase inhibitors. Acta pharm., 55 (1), 69–79.
Mori, K., Inatomi, S., Ouchi, K., Azumi, Y., Tuchida, T., 2009. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebocontrolled clinical trial. Phytother. Res., 23 (3), 367–372. DOI: https://doi.org/10.1002/ptr.2634
Mori, K., Obara, Y., Hirota, M., Azumi, Y., Kinugasa, S., Inatomi, S., Nakahata, N., 2008. Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biol. Pharm. Bull., 31 (9), 1727–1732. DOI: https://doi.org/10.1248/bpb.31.1727
Mukhin, V.A., Kotiranta, H., Knudsen, H., Ushakova, N.V., Votintseva, A.A., Corfixen, P., Chlebicki, A., 2005. Distribution, frequency and biology of Laricifomes officinalis in the Asian part of Russia. Russian Journal of Mycology and Phytopathology, 39 (5), 34–42.
Nakamura, K.N., Yoshikawa, Y., Yamaguchi, Y., Kagota, S., Shinuzuka, K., Kunitomo, M., 2006. Antitumour effect of cordycepin (3’-deoxiadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulation. Anticancer Res., 26, 43–47.
Ng, T.B., 1998. A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). Gen. Pharmacol., 30 (1), 1–4. DOI: https://doi.org/10.1016/S0306-3623(97)00076-1
Ng, T.B., Wang, H., Wan, D.C.C., 2006. Polysaccharopeptide from the Turkey Tail Fungus Trametes versicolor (L.:Fr.) Pilát Inhibits Human Immunodeficiency Virus Type 1 Reverse Transciptase and Protease, Int. J. Med. Mushr., 8 (1), 39–43. DOI: https://doi.org/10.1615/IntJMedMushr.v8.i1.40
Ng, T.B., Wang, H.X., 2005. Pharmacological actions of Cordyceps, a prized folk medicine. J. Pharm. Pharmacol., 57, 1509–1519. DOI: https://doi.org/10.1211/jpp.57.12.0001
Ogris N., 2013. Podatkovna zbirka gliv Slovenije Boletus informaticus. Okamura, K., Suzuki, M., Chihara, T., Fujiwara, A., Fukuda, T., Goto, S., Ichinohe, K., Jimi, S., Kasamatsu, T., Kawai, N., Kizuguchi, K., Mori, S., Nakano, H., Noda, K., Sekiba, K., Suzuki, K., Suzuki, T., Takahashi, K., Takeuchi, K., Takeuchi, S., Yajima, A., Ogawa, N., 1989. Clinical evaluation of Schizophyllan combined with irradiation in patients with cervical cancer. A randomized controlled study, a five-year survival rate. Biotherapy, 1, 103–107. DOI: https://doi.org/10.1007/BF02170141
Opletal, L., Jahodar, L., Chobot, V., Zdansky, P., Lukes, J., Bratova, M., Solichova, D., Bluden, G., Dacke, C.g., Patel, A.V., 1997. Evidence for the anti-hyperlipidaemic activity of the edible fungus Pleurotus ostreatus. Br. J. Biomed. Sci., 54 (4), 240–243.
Parris, K., 2000. The Use of Mushroom Glucans and Proteoglycans in Cancer Treatment. Alternative medicine review, 5(1).
Paterson, R.R., 2008. Cordyceps: a traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry, 69 (7), 1469–95. DOI: https://doi.org/10.1016/j.phytochem.2008.01.027
Pavlik, M., Pavlik, Š., 2013. Wood decomposition activity of oyster mushroom (Pleurotus ostreatus) isolate in situ. Journal of forest science, 59 (1), 28–33. DOI: https://doi.org/10.17221/60/2012-JFS
Peintner, U., Poeder, R., Pumpel, T., 1998. The iceman’s fungi. Mycol. Res., 102 (10), 1153–1162. DOI: https://doi.org/10.1017/S0953756298006546
Pfeiffer, M., 2001. The clinical use of Coriolus versicolor supplementation in HIV+ patients and the impact on CD4 count and viral load. 3rd International Symposium on Mushroom Nutrition. Pietka, J., 2004a. The development of Fomitopsis officinalis mycelium grown on organic media and larch wood under laboratory conditions. Sylwan, 9, 34.42.
Pietka, J., 2004b. Localities of Fomitopsis officinalis in Poland. Acta Mycologica, 39 (1), 33–45. DOI: https://doi.org/10.5586/am.2004.006
Pietka, J., Grzywacz, A., 2005. In situ larch inoculation with Fomitopsis officinalis. Polish Botanical Journal, 50 (2), 225–231.
Pisha, E., Chai, H., Lee, I.S., Chagwedera, T.E., Farnsworth, N.R., Cordell, G.A., Beecher, C.W., Fong, H.H., Kinghorn, A.D., Brown, D.M., Wani, M.C., Wall, M.E., Hieken, T.J., Das Gupta, T.K., Pezzuto, J.M., 1995. Discovery of betulinic acid as a selective inhibitor of human melanoma that
functions by induction of apoptosis. Nature Medicine, 1 (10), 1046–1051.
Pohleven, F., 2010. Judeževo uho ali bezgova goba, najstarejša gojena zdravilna goba. Les, 62 (2), 55.
Powell M., 2010. Medicinal mushrooms: A clinical guide. 1st ed. Mycology press, East Sussex. pp. 128.
Rogers, R., 2011. The Fungal pharmacy, The complete guide to medicinal mushrooms & lichens of north America, 1st ed. North Atlantic Books, Berkeley, 591pp.
Salahuddin, M.B.H.A.H., 2008. Biological Activities Of Schizophyllum Commune Fr., Thesis Submitted In Fulfillment Of The Requirements For The Degree Of Master Of Science, Faculty Of Science, University Of Malaya, Kuala Lumpur, 194 pp.
Schlegel, B., Luhmann, U., Haertl, A., Graefe, U., 2000. Piptamine, a new antibiotic produced by Piptoporus betulinus Lu 9-1. The Journal of Antibiotics, 53 (9), 973–974. DOI: https://doi.org/10.7164/antibiotics.53.973
Seniuk, O.F., Gorovoj, L.F., Beketova, G.V., Savichuk, H.O., Rytik, P.G., Kucherov, I.I., Priluskay, A.B., Prilutsky A.I., 2011. Anti-infective properties of the melanin-glucan complex obtained from medicinal tinder bracket mushroom, Fomes fomentarius (L.: Fr.) Fr. (Aphyllophoromycetideae). DOI: https://doi.org/10.1615/IntJMedMushr.v13.i1.20
Int. J. Med. Mushr. 13 (1), 7–18.
Shi, Y., James, A.E., Benzie, I.F.F., Buswell, J.A., 2002. Genoprotective effects of selected mushroom species, Mushroom Biology and Mushroom Products. Sánchez et al. (eds).
Shimbo, M., Kawagishi, H., Yokogoshi, H., 2005. Erinacine A increases catecholamine and nerve growth factor content in the central nervous system of rats. Nutrition Research, 25, 617–623. DOI: https://doi.org/10.1016/j.nutres.2005.06.001
Stamets, P., 2005. Mycelium running, 1st ed. Ten speed press, Berkeley, 339 pp.
Standish, L.J., Wenner, C.A., Sweet, E.S., Bridge, C., Nelson, A., Martzen, M., Novack, J., Torkelson, C., 2008. Trametes versicolor Mushroom Immune Therapy in Breast Cancer. J. Soc. Integr. Oncol., 6 (3), 122–128.
Suay, I., Arenal, F., Asinsio, F. J., Basilio, A., Cabello, M. A., Díez, M.T., García, J. B., González del
Val, A., Gorrochtegui, J., Hernández, P., Peláez, F., and Vicente, M. F., 2000. Screening of basidiomycetes for antimicrobial activities. Antonie van Leeuwenhoek, 78, 129–139. DOI: https://doi.org/10.1023/A:1026552024021
Thanasekaran, J., Aloysius, P.T., Mathivanan, I., Pitchairaj, G.J., 2010. An extract of the oyster mushroom, Pleurotus ostreatus, increases catalase gene expression and reduces protein oxidation during aging in rats. Chin. Int. Med., 8 (8), 774–780. DOI: https://doi.org/10.3736/jcim20100808
Tochikura, T.S., Nakashima, H., Hirose, K., Yamamoto, N., 1987. A biological response modifier, PSK, inhibits human immunodeficiency virus infection in vitro. Biochemical and Biophysical Research Communications, 148 (2), 726–733. DOI: https://doi.org/10.1016/0006-291X(87)90936-3
Tsukagoshi, S., Hashimoto, Y., Fujii, G., Kobayashi, H., Nomoto, K., Orita, K., 1984. Krestin (PSK). Cancer Treat. Rev., 11 (2), 131–155. DOI: https://doi.org/10.1016/0305-7372(84)90005-7
Tzianabos, A., 2000. Polysaccharide immunomodulators as therapeutic agents: Structural aspects and biologic function. Clin. Microbiol. Rev., 13, 523–533. DOI: https://doi.org/10.1128/CMR.13.4.523
Vrhovec, B., 2010. Zdravilne gobe Slovenije in 100 okusnih gob, 1st ed. Narava, Kranj, 149 pp.
Wasser, P., 2005. Reishi or Ling Zhi (Ganoderma lucidum), Encyclopedia of Dietary Supplements. New York: Marcel Dekker, pp. 842.
Wasser, S.P., Sokolov, D., Reshetnikov, S.V., Timor-Tismenetsky, M., 2000. Dietary Supplements from Medicinal Mushrooms: Diversity of Types and Variety of Regulations. Int. J. Med. Mushr., 2, 1–19. DOI: https://doi.org/10.1615/IntJMedMushr.v2.i1.10
Webster, J., 1991. Schizophyllum in hay bales. Mycologist, 5 (3), 118. DOI: https://doi.org/10.1016/S0269-915X(09)80304-2
Wu, W., Gao X., Cui, X., Qian, G., Chen W., 2000. Review on studies and applications of Cordyceps militaris. Acta Agric. Shanghai, 16, 99–104.
Xu, C.P., Liu, W.W., Liu, F.X., Chen, S.S., Liao, F.Q., Xu, Z., Jiang, L.G., Wang, C.A., Lu, X.H., 1985. A double-blind study of effectiveness of Hericium erinaceus pers therapy on chronic atrophic gastritis. A preliminary report. Chin. Med. J., 98 (6), 455–456.
Ying, J., 1987. Icons of medicinal fungi. Science Press, Beijing, 575 pp.
Yu, C.G., Xu, Z.M., Zhu, Q.K., 1999. Cytoprotective effects of Hericium erinaceus on gastric mucosa in rats. Chinese. J. Gastrent., 1999–2002.
Yue, Q.X., Song, X.Y., Ma, C., Feng, L.X., Guan, S.H., Wu, W.Y., Yang, M., Jiang, B.H., Liu, X., Cui, Y.J., Guo, D.A., 2010. Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells. Phytomedicine: International journal of phytotherapy and phytopharmacology, 17 (8–9), 606–613. DOI: https://doi.org/10.1016/j.phymed.2009.12.013
Zeng, F., Zhao, C., Pang, J., Lin, Z., Huang, Y., Liu, B., 2013. Chemical properties of a polysaccharide purified from solid-state fermentation of auricularia auricular and its biological activity as a hypolipidemic agent. J. Food Sci., 78 (9), 1470–1475. DOI: https://doi.org/10.1111/1750-3841.12226
Zhou, Sh., Gao, Y., Chen, G., Dai, X., Ye, J., Gao, H., 2002. A phase I = II study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. (Ling Zhi, reishi mushroom) extract in patients with chronic hepatitis B. Int. J. Med. Mushrooms, 4 (4), 321–328. DOI: https://doi.org/10.1615/IntJMedMushr.v4.i4.50
Zhou, X.X., Meyer, C.U., Schmidtke, P., Zeep, F., 2002. Effect of cordycepin on interleukin-10 production of human peripheral blood mononuclear cells. Eur. J. Pharmacol., 453, 309–317. DOI: https://doi.org/10.1016/S0014-2999(02)02359-2
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
